Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds in the form of …
Is Investing in Moderna Stock (NASDAQ:MRNA) Simply Dead Money?
view original post
Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds in the form of …